Moderna’s mRNA RSV Vaccine Effective in Older Adults
Moderna’s mRNA-based RSV vaccine was effective at preventing RSV-associated lower respiratory tract disease in adults ages 60 and older, according to results of the randomized ConquerRSV trial. The mRNA-1345 vaccine was 83.7% effective (95.88% CI 66%-92.2%) in preventing RSV-associated lower respiratory tract disease with at least two signs or symptoms, and similarly effective (82.4%) against […]
6 Months of U.S. Data Support Safety of mRNA COVID Vaccines
Nearly all local and systemic adverse events (AEs) reported after Pfizer or Moderna’s COVID-19 vaccines were mild and transient, and only a fraction of individuals reported seeking medical care, according to data from the Vaccine Adverse Event Reporting System (VAERS) and CDC’s v-safe tracker. Out of almost 300 million mRNA vaccine doses administered in the […]
FDA Authorizes COVID Booster Shots for Certain Populations
After weeks of speculation, the FDA amended the emergency use authorizations (EUAs) for Pfizer and Moderna‘s COVID-19 vaccines to include an additional booster dose for certain immunocompromised people, the agency said late Thursday. These populations include solid-organ transplant recipients or others diagnosed with conditions “considered to have a similar level of immunocompromise.” The FDA kept […]